MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas.

Walls, G; Lemos, M; Javid, M; Bazan-Peregrino, M; Jeyabalan, J; Reed, A; Harding, B; Tyler, D; Stuckey, D; Piret, S; Christie, P; Ansorge, O; Clarke, K; Seymour, L; Thakker, R

Journal article

MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas.

Abstract:: Multiple endocrine neoplasia type 1 (MEN1) is characterized by the combined occurrence of pituitary, pancreatic, and parathyroid tumors showing loss of heterozygosity in the putative tumor suppressor gene MEN1. This gene encodes the protein menin, the overexpression of which inhibits cell proliferation in vitro. In this study, we conducted a preclinical evaluation of MEN1 gene therapy in pituitary tumors of Men1(+/-) mice, using a recombinant nonreplicating adenoviral serotype 5 vector that contained the murine Men1 cDNA under control of a cytomegalovirus promoter (Men1.rAd5). Pituitary tumors in 55 Men1(+/-) female mice received a transauricular intratumoral injection of Men1.rAd5 or control treatments, followed by 5-bromo-2-deoxyuridine (BrdUrd) in drinking water for four weeks before magnetic resonance imaging (MRI) and immunohistochemical analysis. Immediate procedure-related and 4-week mortalities were similar in all groups, indicating that the adenoviral gene therapy was not associated with a higher mortality. Menin expression was higher in the Men1.rAd5-treated mice when compared with other groups. Daily proliferation rates assessed by BrdUrd incorporation were reduced significantly in Men1.rAd5-injected tumors relative to control-treated tumors. In contrast, apoptotic rates, immune T-cell response, and tumor volumes remained similar in all groups. Our findings establish that MEN1 gene replacement therapy can generate menin expression in pituitary tumors, and significantly reduce tumor cell proliferation.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Walls, G., Lemos, M., Javid, M., Bazan-Peregrino, M., Jeyabalan, J., Reed, A., Harding, B., Tyler, D., Stuckey, D., Piret, S., Christie, P., Ansorge, O., Clarke, K., Seymour, L., & Thakker, R. (2012). MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas. Cancer Research, 72(19), 5060–5068.

MLA Style

Walls, G., et al. “MEN1 Gene Replacement Therapy Reduces Proliferation Rates in a Mouse Model of Pituitary Adenomas.” Cancer Research, vol. 72, no. 19, 2012, pp. 5060–68.

Chicago Style

Walls, G, M Lemos, M Javid, M Bazan-Peregrino, J Jeyabalan, A Reed, B Harding, et al. 2012. “MEN1 Gene Replacement Therapy Reduces Proliferation Rates in a Mouse Model of Pituitary Adenomas.” Cancer Research 72 (19): 5060–68.
Share
Print